Biotechnology

#Biotechnology #Covid-19 #Drug development

Molecular ‘cookie cutter’ method could provide key for COVID drug discovery

Researchers from the University of Birmingham are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs. The encounter complex is formed when the COVID-19 spike latches onto a binding site on an ACE-2 receptor,… Read More

#News

#AstraZeneca #Biotechnology #Covid-19 #Immunology / Virology & Vaccines #Pfizer

Existing vaccines may protect against coronavirus variants

Scientists at the University of Oxford have released pre-print data measuring the level of antibodies that can neutralise or stop infection from variants that are circulating in South Africa, Brazil and elsewhere. The data suggests that natural- and vaccine-induced antibodies can still neutralise these variants, but at lower levels. Importantly,… Read More

#Covid-19 #News

#Biotechnology #Cancer research #Immunology / Virology & Vaccines #Immunotherapy #mRNA

Consortium awarded EU Commission TIGER Grant of €6.9 million

eTheRNA Immunotherapies, a clinical-stage company developing mRNA-based immunotherapies as off-the-shelf products for the treatment of cancer and infectious diseases, has announced the award of a TIGER grant of €6.9 million from the EU commission. The grant was awarded to a consortium led by eTheRNA and will be used to accelerate the development of… Read More

#Cancer Research #News

#Bioinformatics #Biotechnology #Informatics #Pharmaceutical research

PerkinElmer expands informatics capabilities in biologics drug discovery

Biotechnology company PerkinElmer has announced its documentation, workflow and decision-making informatics platform, Signals, is expanding to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With the collaboration, pharmaceutical and academic research… Read More

#News

#Biotechnology #Drug delivery #Drug development #Events

Join NanoTemper Technologies’ Prometheus Panta tour

NanoTemper Technologies will be running a case study and walk through of Prometheus Panta. Join the company on 30 March to learn how to make formulation workflow more efficient with multi-parameter stability characterisation. This event will provide new perspectives on data and will look at how running thermal unfolding, particle… Read More

#News

#Biologics / Biotechnology #Biotechnology #iPSC

Axol Bioscience and Censo Biotechnologies announce merger

Axol Bioscience, provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies,  have signed a merger agreement. The new entity will become a provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modelling for… Read More

#News

#Biotechnology #Clinical diagnostics #Life sciences

Bio-Techne certified for its Bristol manufacturing facility

Bio-Techne, a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities, announced that its Bristol site has received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for research use. ISO 9001:2015 is an internationally recognised quality standard intended… Read More

#News

#Biotechnology #Life sciences #Pharma #Report #Therapeutics

Report shows growth in advanced therapeutics in Stockholm

A new report from Invest Stockholm on Advanced Therapeutics Manufacturing and Life Science in the Stockholm region showed that the sector has grown by 66% in the past four years. Collaboration between local tech and pharma industries are expected to further enhance Stockholm’s competitiveness and growth in the future. Both… Read More

#Editor's Choice #News #Trending News

#Biopharmaceuticals #Biotechnology #Drug discovery #Market reporting #Pharmatech

Pharma report predicts growth of contract services by 2025

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive Covid-19 legacies – including accelerated development timelines, remote trials and new technologies in genetic and target screening. The report anticipates breakthroughs in… Read More

#Market Reports #News

#Biotechnology #Drug development #Molecular research

AMRI scoops Forbes’ best employer accolade

Albany Molecular Research (AMRI), provider of advanced contract research, development and manufacturing solutions, has been included in America’s Best Employers 2021 list, published by Forbes. AMRI was included in the Drugs and Biotechnology industry category of the ranking. Its 3,100 employees provide scientific solutions across the R&D and manufacturing continuum… Read More

#News

#Biopharmaceuticals #Biotechnology #Drug delivery #Drug development

Amryt and Medison distribution agreement for metreleptin in Canada

Global biopharmaceutical company Amryt has signed a distribution agreement with Medison Pharma Canada to distribute Myalepta (metreleptin) in Canada. Amryt is a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising novel treatments for rare diseases. Medison is a commercial partner of global biotech companies that provide integrated services… Read More

#News

#Biotechnology #Cell culture #Software

Automated solution aims to boost cell culture and harvesting process

Automation software developers Celltrio and Biosero will integrate Biosero’s Green Button Go Automation Scheduling Software with Celltrio’s RoboCell Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a new end-to-end system. The aim is that Green Button Go will accelerate the cell culture and harvesting… Read More

#News

#Biopharmaceutical #Bioproduction #Biotechnology #Clinical diagnostics #Life sciences

Advanced Biological Safety Cabinet launched

Thermo Fisher Scientific has launched the Thermo Scientific Herasafe 2025 BSC, for the safe sample handling needs of life science applications. It is a Class II Biological Safety Cabinet (BSC) designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic and biopharmaceutical laboratories. According to Thermo Fisher… Read More

#News

#Big pharma #Biopharmaceuticals #Biotechnology #Covid-19 #Vaccines

Supply chains key to successful COVID-19 vaccine roll-out 

Resilience in pharma and biotech supply chains is essential for the roll out of the Covid-19 vaccine, says Karl Lauri, ERP/MRP software manufacturer and distributor MRPeasy.com.  While the pandemic has highlighted the strength of the UK’s pharmaceutical and biotechnology sector, it has also shed light on the vulnerabilities of intricate, geographically extended and… Read More

#Covid-19 #News

#Biotechnology #Cell and gene therapy #Pharmaceuticals

WuXi AppTec acquires OXGENE to strengthen cell and gene therapy service

WuXi AppTec, provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, has completed the acquisition of OXGENE, a UK-based contract research and development organisation that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the… Read More

#Editor's Choice #News

#Antibodies #Biotechnology

Exclusive: The man behind the next generation antibody discovery platform

Last year IONTAS, a biotechnology company focused on antibody discovery and development, entered into a licensing agreement with Bristol Myers Squibb for its proprietary mammalian display. John McCafferty, nuclease directed mammalian display inventor and co-inventor of antibody phage display, told Lu Rahman about this breakthrough work. The company operates as… Read More

#Exclusive Content #News #Opinion